Cocrystallization of lenvatinib and temozolomide to improve the performance in terms of stability, dissolution, and tabletability

Abstract

Cocrystallization of two anti-melanoma drugs, lenvatinib and temozolomide, resulted in two drug–drug cocrystal solvates presenting improved performance in terms of stability, dissolution, and tabletability, which show great potential to be developed as a drug combination.